Cargando…
The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update
Nicotinamide N-methyltransferase (NNMT) catalyzes the N-methylation reaction of nicotinamide, using S-adenosyl-L-methionine as the methyl donor. Enzyme overexpression has been described in many non-neoplastic diseases, as well as in a wide range of solid malignancies. This review aims to report and...
Autores principales: | Campagna, Roberto, Pozzi, Valentina, Spinelli, Graziana, Sartini, Davide, Milanese, Giulio, Galosi, Andrea Benedetto, Emanuelli, Monica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393883/ https://www.ncbi.nlm.nih.gov/pubmed/34439880 http://dx.doi.org/10.3390/biom11081214 |
Ejemplares similares
-
Nicotinamide N-Methyltransferase as Promising Tool for Management of Gastrointestinal Neoplasms
por: Pozzi, Valentina, et al.
Publicado: (2022) -
Beyond Nicotinamide Metabolism: Potential Role of Nicotinamide N-Methyltransferase as a Biomarker in Skin Cancers
por: Campagna, Roberto, et al.
Publicado: (2021) -
Nicotinamide N-Methyltransferase in Head and Neck Tumors: A Comprehensive Review
por: Togni, Lucrezia, et al.
Publicado: (2021) -
Recent Advances in the Management of Clear Cell Renal Cell Carcinoma: Novel Biomarkers and Targeted Therapies
por: Schiavoni, Valentina, et al.
Publicado: (2023) -
Bladder Cancer Chemosensitivity Is Affected by Paraoxonase-2 Expression
por: Fumarola, Stefania, et al.
Publicado: (2020)